Pirnabine
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | 68298-00-0 |
| PubChem (CID) | 50137 |
| ChemSpider | 45469 |
| UNII |
S3FHL03F60  Y |
| Chemical and physical data | |
| Formula | C19H24O3 |
| Molar mass | 300.391 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.[1]
References
| Receptor (ligands) |
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||||||||
| Enzyme (modulators) |
| ||||||||||||||||||
| Others |
| ||||||||||||||||||
| |||||||||||||||||||
This article is issued from Wikipedia - version of the 7/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.